Articles from PROLLENIUM

PROLLENIUM®, a global leader in medical aesthetic innovation, today announced the launch of the PACE Training & Education Portal, a digital learning platform designed to expand access to the PACE (PROLLENIUM® Advanced Clinical Education) program. The portal provides aesthetic practitioners with a centralized destination for training and professional development through personalized learning pathways and gamified engagement, combining physician-led instruction with practical guidance tailored for real-world clinical settings.

A high concentration medical-grade polydeoxyribonucleotide (PDRN) formulation designed for advanced skin rejuvenation

PROLLENIUM® Medical Technologies, a privately held medical aesthetics company, has appointed Erick Brenner as Chief Executive Officer, effective immediately. Brenner succeeds Walter Geiger, who has served as Interim CEO since April 2025, and will return to his role as Operating Partner at ARCHIMED, PROLLENIUM®’s majority shareholder.

PROLLENIUM®, a pioneer in regenerative and medical aesthetics, has been recognized as the Industry Partner of the Year at the Aesthetic Next 2025 conference. The award acknowledges PROLLENIUM®’s unwavering commitment to innovation, education, and collaborative partnership within the aesthetic community.